11/12/2025
Menopause misinformation is everywhere — and it’s costing women clarity, time, and trust.
In a recent BMJ article, it calls out a growing problem: a sharp rise in commercial menopause services offering hormone panels and “personalised” tests — often costing hundreds — marketed as precision care.
But here’s what the evidence actually shows:
💫 There’s no defined therapeutic window for menopausal hormone therapy.
💫 Hormone testing can’t predict who will benefit from treatment, when the final menstrual period will occur, or when it’s safe to stop contraception.
💫For women over 45 with clear symptoms, major clinical bodies — including the British Menopause Society, ACOG, and NICE — all agree that menopause is a clinical diagnosis, based on symptoms and menstrual history, not numbers on a lab report.
The authors warn that this surge in unnecessary testing reflects a deeper issue — the commercialisation of women’s health.
More panels. More marketing. More promises of “customised” solutions that sound scientific but lack meaningful evidence.
As noted in the article; “For midlife women, effective treatment begins not with numbers, but with listening.”
And I couldn’t agree more.
In my practice, I use labs when they change the plan.
But in menopause care, chasing numbers can distract from the real work: understanding how a woman feels, what she’s experiencing day to day, and what her goals actually are.
Let’s bring menopause care back to where it belongs — in real conversations, grounded in science and compassion, not marketing. 🌿
BMJ 2025; 390 :r1695 doi:10.1136/bmj.r1695